Trials of radical radiotherapy versus chemotherapy plus radical radiotherapy in non-small cell lung cancerCULLEN, M. H.Seminars in oncology. 1994, Vol 21, Num 3, pp 34-41, issn 0093-7754, SUP4Article

Dose-response relationships in testicular cancerCULLEN, M. H.European journal of cancer : (1990). 1991, Vol 27, Num 7, pp 817-818Article

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancerCULLEN, M. H; ZATLOUKAL, P; SÖRENSON, S et al.Annals of oncology. 2008, Vol 19, Num 5, pp 939-945, issn 0923-7534, 7 p.Article

Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagusALLEN, S. M; DUFFY, J. P; DARNTON, S. J et al.Cancer chemotherapy and pharmacology. 1996, Vol 37, Num 5, pp 496-498, issn 0344-5704Article

A phase II study on mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagusALLEN, S. M; DUFFY, J. P; WALKER, S. J et al.Clinical oncology (Springer. Print). 1994, Vol 6, Num 2, pp 91-95, issn 0936-6555Article

Advances in the management of cytotoxic drug-induced nausea and vomitingFREEMAN, A. J; CULLEN, M. H.Journal of clinical pharmacy and therapeutics (Print). 1991, Vol 16, Num 6, pp 411-421, issn 0269-4727Article

Treatment of oesophageal small cell carcinoma by combined chemotherapy and surgical resection: report of two cases and review of published casesWALKER, S. J; STEEL, A; CULLEN, M. H et al.Thorax. 1989, Vol 44, Num 9, pp 751-752, issn 0040-6376, 2 p.Article

A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphomaBESSELL, E. M; BURTON, A; JONES, E. L et al.Annals of oncology. 2003, Vol 14, Num 2, pp 258-267, issn 0923-7534, 10 p.Article

Primary chemotherapy after orchidectomy for stage I and II nonseminoma : Germ cell tumorsHORWICH, A; CULLEN, M. H; STENNING, S. P et al.Seminars in oncology. 1998, Vol 25, Num 2, pp 154-159, issn 0093-7754Article

A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma NHLSMITH, G. M; CHILD, J. A; CULLEN, M. H et al.Hematological oncology. 1996, Vol 14, Num 4, pp 193-201, issn 0278-0232Article

Long-term toxicity of chemotherapy for testicular cancer : the cost of cureSTUART, N. S. A; WOODROFFE, C. M; GRUNDY, R et al.British journal of cancer. 1990, Vol 61, Num 3, pp 479-484, issn 0007-0920, 6 p.Article

A new approach to the treatment of advanced high-grade non-Hodgkin's lymphoma-intensive two-phase chemotherapySTUART, N. S. A; BLACKLEDGE, G. R. P; MACLENNAN, I. C. M et al.Cancer chemotherapy and pharmacology. 1988, Vol 22, Num 2, pp 141-146, issn 0344-5704Article

Chemotherapy for poor risk germ cell tumours: an independent evaluation of the POMB/ACE regimeCULLEN, M. H; HARPER, P. G; WOODROFFE, C. M et al.British journal of urology (Print). 1988, Vol 62, Num 5, pp 454-460, issn 0007-1331, 7 p.Article

Optimal planning target volume for stage I testicular seminoma : A medical research council randomized trialFOSSA, S. D; HORWICH, A; GROSCH, E. J et al.Journal of clinical oncology. 1999, Vol 17, Num 4, pp 1146-1154, issn 0732-183XArticle

A Phase II trial of cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagusSTEYN, R. S; VIJEYASINGAM, R; DARNTON, S. J et al.Clinical oncology (Springer. Print). 1998, Vol 10, Num 3, pp 170-172, issn 0936-6555Article

Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphomaBAILEY, N. P; STUART, N. S. A; FARISH, J et al.Annals of oncology. 1998, Vol 9, Num 6, pp 633-638, issn 0923-7534Article

Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapyFOSSI, S. D; OLIVER, R. T. D; KAYE, S. B et al.European journal of cancer (1990). 1997, Vol 33, Num 9, pp 1380-1387, issn 0959-8049Article

Quality of life after treatment for testicular cancer : the patient's viewSTUART, N. S. A; GRUNDY, R; WOODROFFE, C. M et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 3, pp 291-294, issn 0277-5379Article

Mitomycin, ifosafamide and cis-platin in non-small cell lung cancer: treatment good enough to compareCULLEN, M. H; JOSHI, R; CHETIYAWARDANA, A. D et al.British journal of cancer. 1988, Vol 58, Num 3, pp 359-361, issn 0007-0920Article

Testing new drugs in untreated small cell lung cancer may prejudice the results of standard treatment: a phase II study of oral idarubicin in extensive diseaseCULLEN, M. H; SMITH, S. R; BENFIELD, G. F. A et al.Cancer treatment reports. 1987, Vol 71, Num 12, pp 1227-1230, issn 0361-5960Article

Management of febrile neutropenia: ESMO Clinical Practice GuidelinesDE NAUROIS, J; NOVITZKY-BASSO, I; GILL, M. J et al.Annals of oncology. 2010, Vol 21, issn 0923-7534, v252-v256, SUP5Article

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours : a prospective trial (MRC TE17)DEARNALEY, D. P; FOSSA, S. D; COOK, P. A et al.British journal of cancer. 2005, Vol 92, Num 12, pp 2107-2113, issn 0007-0920, 7 p.Article

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer : Effects on survival and quality of lifeCULLEN, M. H; BILLINGHAM, L. J; TRASK, C et al.Journal of clinical oncology. 1999, Vol 17, Num 10, pp 3188-3194, issn 0732-183XArticle

A Phase II trial of preoperative mitomycin, cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagusDARNTON, S. J; FERRY, D. R; CULLEN, M. H et al.Clinical oncology (Springer. Print). 1998, Vol 10, Num 6, pp 372-376, issn 0936-6555Article

Page / 3